Anna Ellsworth

1.2k total citations
31 papers, 939 citations indexed

About

Anna Ellsworth is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Anna Ellsworth has authored 31 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Physiology, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Immunology and Allergy. Recurrent topics in Anna Ellsworth's work include Asthma and respiratory diseases (17 papers), Allergic Rhinitis and Sensitization (9 papers) and Respiratory and Cough-Related Research (8 papers). Anna Ellsworth is often cited by papers focused on Asthma and respiratory diseases (17 papers), Allergic Rhinitis and Sensitization (9 papers) and Respiratory and Cough-Related Research (8 papers). Anna Ellsworth collaborates with scholars based in United States, United Kingdom and Sweden. Anna Ellsworth's co-authors include Rakez Kayed, Nemil Bhatt, Urmi Sengupta, E. Philpot, Salomé McAllen, Mauro Montalbano, Nicha Puangmalai, Robert M. Naclerio, John Given and Harold B. Kaiser and has published in prestigious journals such as Scientific Reports, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Anna Ellsworth

31 papers receiving 915 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Ellsworth United States 16 770 290 288 181 117 31 939
Kristen E. Belmonte United States 13 360 0.5× 282 1.0× 32 0.1× 256 1.4× 117 1.0× 19 724
Charles A. Rizzo United States 18 308 0.4× 216 0.7× 70 0.2× 302 1.7× 203 1.7× 30 779
MG Belvisi United Kingdom 12 300 0.4× 170 0.6× 35 0.1× 233 1.3× 178 1.5× 21 592
Ad F. Roffel Netherlands 20 413 0.5× 209 0.7× 31 0.1× 571 3.2× 324 2.8× 43 985
Irina M. Zemtsova Germany 11 110 0.1× 27 0.1× 23 0.1× 232 1.3× 77 0.7× 12 657
Peter R. Butchers United Kingdom 13 429 0.6× 284 1.0× 91 0.3× 224 1.2× 95 0.8× 19 721
Ana Lukić United States 17 263 0.3× 62 0.2× 8 0.0× 326 1.8× 59 0.5× 27 762
Pedro Ayuso Spain 18 259 0.3× 31 0.1× 77 0.3× 198 1.1× 12 0.1× 38 716
Rafael Lozano Spain 12 106 0.1× 70 0.2× 18 0.1× 86 0.5× 45 0.4× 18 657
H. Meurs Netherlands 13 573 0.7× 369 1.3× 74 0.3× 266 1.5× 127 1.1× 17 875

Countries citing papers authored by Anna Ellsworth

Since Specialization
Citations

This map shows the geographic impact of Anna Ellsworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Ellsworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Ellsworth more than expected).

Fields of papers citing papers by Anna Ellsworth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Ellsworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Ellsworth. The network helps show where Anna Ellsworth may publish in the future.

Co-authorship network of co-authors of Anna Ellsworth

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Ellsworth. A scholar is included among the top collaborators of Anna Ellsworth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Ellsworth. Anna Ellsworth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Montalbano, Mauro, Elizabeth Jaworski, Stephanie García, et al.. (2021). Tau Modulates mRNA Transcription, Alternative Polyadenylation Profiles of hnRNPs, Chromatin Remodeling and Spliceosome Complexes. Frontiers in Molecular Neuroscience. 14. 742790–742790. 22 indexed citations
2.
Puangmalai, Nicha, Nemil Bhatt, Mauro Montalbano, et al.. (2020). Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer’s disease, progressive supranuclear palsy and dementia with Lewy bodies. Cell Death and Disease. 11(5). 314–314. 75 indexed citations
3.
Montalbano, Mauro, Salomé McAllen, Filippa Lo Cascio, et al.. (2020). TDP-43 and Tau Oligomers in Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia. Neurobiology of Disease. 146. 105130–105130. 77 indexed citations
4.
McAllen, Salomé, Urmi Sengupta, Nicha Puangmalai, et al.. (2019). Tau oligomers mediate aggregation of RNA‐binding proteins Musashi1 and Musashi2 inducing Lamin alteration. Aging Cell. 18(6). e13035–e13035. 31 indexed citations
5.
Cascio, Filippa Lo, Nicha Puangmalai, Anna Ellsworth, et al.. (2019). Toxic Tau Oligomers Modulated by Novel Curcumin Derivatives. Scientific Reports. 9(1). 19011–19011. 51 indexed citations
6.
Lee, Laurie A., et al.. (2014). Growth Velocity Reduced with Once-Daily Fluticasone Furoate Nasal Spray in Prepubescent Children with Perennial Allergic Rhinitis. The Journal of Allergy and Clinical Immunology In Practice. 2(4). 421–427. 29 indexed citations
7.
Woodcock, Ashley, Eugene R. Bleecker, Jan Lötvall, et al.. (2013). Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma. CHEST Journal. 144(4). 1222–1229. 73 indexed citations
8.
Woodcock, Ashley, Eugene R. Bleecker, Jan Lötvall, et al.. (2012). Efficacy and safety of fluticasone furoate (FF)/vilanterol (VI) compared with fluticasone propionate/salmeterol combination (FP/SAL) in adults and adolescents with persistent asthma. 40. 1795. 2 indexed citations
9.
Lincourt, William R., et al.. (2010). Repeat Dosing of Albuterol via Metered-Dose Inhaler in Infants With Acute Obstructive Airway Disease. Pediatric Emergency Care. 26(3). 197–202. 9 indexed citations
10.
11.
Meltzer, Eli O., et al.. (2008). Efficacy and safety of once‐daily fluticasone furoate nasal spray in children with seasonal allergic rhinitis treated for 2 wk. Pediatric Allergy and Immunology. 20(3). 279–286. 25 indexed citations
12.
Fokkens, Wytske J., Rain Jögi, S.M. Reinartz, et al.. (2007). Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy. 62(9). 1078–1084. 85 indexed citations
13.
Kaiser, Harold B., et al.. (2007). Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology. 119(6). 1430–1437. 114 indexed citations
14.
15.
16.
Kerwin, Edward, Martha Tarpay, Michael Noonan, et al.. (2006). Safety and Efficacy of a New Albuterol Hydrofluoroalkane Formulation for Treating Asthma Symptoms in Children Two to Less Than Four Years of Age. Pediatric Asthma Allergy & Immunology. 19(2). 81–90. 2 indexed citations
17.
18.
LaForce, Craig, et al.. (2005). The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma. Annals of Allergy Asthma & Immunology. 95(1). 66–71. 51 indexed citations
19.
House, Karen, et al.. (2004). The Safety of Fluticasone propionate/Salmeterol Diskus® in Pediatric Patients Ages 4 –11 with Asthma. CHEST Journal. 126(4). 911S–911S. 8 indexed citations
20.
Horn, John R., et al.. (1987). Chlorpropamide pharmacokinetics in young healthy adults and older diabetic patients.. PubMed. 6(2). 162–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristen E. Belmonte Breakdown of academic impact, for papers by Charles A. Rizzo Breakdown of academic impact, for papers by MG Belvisi Breakdown of academic impact, for papers by Ad F. Roffel Breakdown of academic impact, for papers by Irina M. Zemtsova Breakdown of academic impact, for papers by Peter R. Butchers Breakdown of academic impact, for papers by Ana Lukić Breakdown of academic impact, for papers by Pedro Ayuso Breakdown of academic impact, for papers by Rafael Lozano Breakdown of academic impact, for papers by H. Meurs
Rankless by CCL
2026